check_circleStudy Completed
Healthy
Bayer Identifier:
15853
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation
Trial purpose
The purpose of this study is to determine the irritancy potential of azelaic acid pre-foam formulation.
Key Participants Requirements
Sex
BothAge
18 - 65 YearsTrial summary
Enrollment Goal
40Trial Dates
September 2011 - December 2011Phase
Phase 1Could I Receive a placebo
NoProducts
Finacea® (azelaic acid) Foam, 15% (Azelaic Acid, BAY39-6251)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Robert I. Cooper, MD | Fargo, 58104, United States |
Primary Outcome
- irritancy rating scaleskin reaction as well as superficial layer effects will be scored according to standardized scalesdate_rangeTime Frame:21 daysenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
Basic ScienceAllocation
RandomizedBlinding
Double BlindAssignment
Parallel AssignmentTrial Arms
4